Japan's AI code puts 'explain' to the test
August 25, 2026
| Toko Sekiguchi
Japan’s finalized generative AI principles code gives AI providers clearer boundaries around what they are expected to disclose, while putting more substance around what it means to “explain” when they do not.
US DOJ patent deposit stance wins narrow embrace in Corteva-Inari ruling
August 24, 2026
| Melissa Ritti
A summary judgment Friday clarified one side of an important boundary for biological patent deposits — public availability does not create a public license. But the question of whether Inari Agriculture's cond... (more story)
US patent litigation drawn into broader third-party funding disclosure debate
August 24, 2026
| Steve Scherer
Third-party litigation funders have suffered setbacks in a disclosure fight that includes patent disputes, with the USITC considering new requirements alongside action by states, Congress and a federal rules c... (more story)
Early test of USPTO's ex parte preorder filing leads to re-exam denial
August 21, 2026
| Nick Robertson
The US Patent and Trademark Office determined last week that a request for ex parte re-examination of a Xiamen PVTECH Corp. patent does not raise a substantial new question of patentability, an early example o... (more story)
India lets AI into patent examination — but who's really deciding?
August 21, 2026
| Freny Patel
India's Patent Office is putting formal rules around the use of artificial intelligence across patent examination while drawing a line against allowing AI to replace examiner judgment. The safeguards look robu... (more story)
Trademark friction evinces growing commercial stakes in US higher education
August 20, 2026
| Melissa Ritti
US colleges and universities have long protected their intellectual property, but a series of recent trademark disputes show how aggressively some are enforcing their rights — including against each other.
US Congress considers 'Netflix for antibiotics' funding model
August 20, 2026
| Nick Robertson
A bill to de-link antimicrobial innovation funding from volume and instead rely on fixed-rate funding for new drugs is gaining momentum in Washington, building off similar successful programs in the UK and Swe... (more story)
Collapse of German carmakers' LNG doesn’t mean collective bargaining is dead
August 20, 2026
| Khushita Vasant and Inbar Preiss
The collapse of Germany’s proposed automotive licensing negotiation group lays bare deep uncertainty over LNGs. Divergent EU, UK and US antitrust approaches, established patent pools and limited practical expe... (more story)